DANBURY, Conn. (AP) _ MannKind Corp. (MNKD) on Thursday reported a loss of $26 million in its first quarter.

The Danbury, Connecticut-based company said it had a loss of 10 cents per share.

The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 10 cents per share.

The biopharmaceutical company posted revenue of $12 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $10.4 million.